TENECTEPLASE 40 mg INJECTION
Nuclear Power Corporation Of India Limited · Narora, Uttar Pradesh · Pharmaceuticals · open
Key facts
- Published: 23 Oct 2026
- Closing date: 16 Nov 2026
- Status: open
- Status as of: 24 Oct 2026 22:11 UTC
- Ministry: PMO
- Department: Department Of Atomic Energy
- Office: NAPS
Description
Supply of 11 units of TENECTEPLASE 40 mg INJECTION to Narora Atomic Power Station, Uttar Pradesh. Bid validity is 90 days from the end date. EMD and ePBG are not required.
Eligibility & requirements
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Seller declaration stating that the offered product is manufactured by them, as per Annexure-E, Undertaking as per Annexure-III (for One Bid Per Bidder), Supporting documents to prove eligibility for relaxation from experience criteria, where applicable, Supporting documents to prove eligibility for relaxation from turnover criteria, where applicable, Relevant documentary evidence for MSE purchase preference, where applicable
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Total value wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (1)
- TENECTEPLASE 40 mg INJECTION — Qty: 11 pieces
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Medicine supply — Pharmaceuticals · Jammu and Kashmir
- Medicine: expendable items — Pharmaceuticals · Uttarakhand
- Supply of Medicines and Biochemistry Reagents — Pharmaceuticals · Himachal Pradesh · ₹22.0L